Which pharmaceutical product holds the record for the fastest FDA approval through the Accelerated Approval pathway, going from application to market in just 2.5 months?

Product launches in the pharmaceutical industry can make or break companies and change countless lives. The FDA's approval process typically takes years, but some revolutionary treatments have received accelerated pathways due to their life-saving potential. This trivia tests your knowledge of one of the most notable expedited product launches in modern medicine - a milestone that changed how we approach certain approval processes for critical treatments.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Gleevec (imatinib) for chronic myeloid leukemia in 2001
Sovaldi (sofosbuvir) for hepatitis C in 2013
Keytruda (pembrolizumab) for melanoma in 2014
Spinraza (nusinersen) for spinal muscular atrophy in 2016